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MicroRNAs are critical post-transcriptional regula-
tors of hematopoietic cell-fate decisions, though
little remains known about their role in aging he-
matopoietic stem cells (HSCs). We found that the
microRNA-212/132 cluster (Mirc19) is enriched in
HSCs and is upregulated during aging. Both overex-
pression and deletion of microRNAs in this cluster
leads to inappropriate hematopoiesis with age. En-
forced expression of miR-132 in the bone marrow
of mice led to rapid HSC cycling and depletion.
A genetic deletion of Mirc19 in mice resulted in
HSCs that had altered cycling, function, and survival
in response to growth factor starvation. We found
that miR-132 exerted its effect on aging HSCs by
targeting the transcription factor FOXO3, a known
aging associated gene. Our data demonstrate that
Mirc19 plays a role in maintaining balanced hemato-
poietic output by buffering FOXO3 expression. We
have thus identified it as a potential target that might
play a role in age-related hematopoietic defects.
INTRODUCTION
Hematopoietic stem cells (HSCs) are the source of most all the
immune cells in our body (Orkin and Zon, 2008). A complex
gene regulatory network tightly regulates the function and sur-
vival of HSCs to ensure balanced and appropriate hematopoietic
output (Novershtern et al., 2011). Alteration of the HSC niche and
deregulation in cell-intrinsic properties such as HSC self-renewal
and cycling, metabolism, and survival can have drastic conse-
quences on hematopoietic output (Passegue´ et al., 2005; Suda
et al., 2011). As an organism ages, the balance between HSC
self-renewal, function, and survival is drastically altered (Geiger
et al., 2013), and this might lead to deleterious consequences
such as the inability to effectively combat infection and the onset
of autoimmune disease or hematologic cancers (Frasca and
Blomberg, 2011; Henry et al., 2011).Aged HSCs are characterized by increased self-renewal po-
tential, loss of long-term reconstitution capability, myeloid-
biased differentiation and a change in niche localization. As
a consequence, aged mice demonstrate an accumulation of
phenotypically defined HSCs with a poor ability to home to the
bone marrow niche (Geiger et al., 2013). These aged HSCs
also develop a requirement for basal autophagy for survival,
because replication stress and the accumulation of reactive
oxygen species have harmful consequences on HSC function
with age (Flach et al., 2014; Tothova et al., 2007). The loss of
critical autophagic factors is often associated with altered cell
cycling of HSCs, and leads to apoptosis and a rapid loss of
HSC numbers in aged mice (Miyamoto et al., 2007; Rubinsztein
et al., 2011; Warr et al., 2013). A critical balance between cell
cycling and differentiation, and survival of aged HSCs must
therefore be established to maintain normal hematopoietic
output.
Several genetic and epigenetic factors have been identified as
important regulators of hematopoietic stem cell aging (Geiger
et al., 2013; Rossi et al., 2012; Sun et al., 2014). To date, how-
ever, little is known about the role of noncoding RNAs in the regu-
lation of hematopoietic stem cells with age. MicroRNAs, a class
of small-noncoding RNAs, are important post-transcriptional
regulators of hematopoietic cell-fate decisions (Baltimore et al.,
2008; Chen et al., 2004; Gangaraju and Lin, 2009). They alter
cell fate by negatively regulating gene expression through direct
binding to the 30untranslated regions of targetmRNAs (Filipowicz
et al., 2008). Importantly, as post-transcriptional regulators they
function to buffer the protein expression of their targets and
confer robustness to biological processes such as lineage
commitment (Ebert and Sharp, 2012; Mukherji et al., 2011; Stro-
vas et al., 2014).
Several microRNAs have been found to regulate normal func-
tion of HSCs, including cell cycling and engraftment potential
(Guo et al., 2010; Lechman et al., 2012; Song et al., 2013;
Zhao et al., 2013). However, the role of microRNAs in regulating
aging HSC function remains unclear. In this work, we studied a
previously unappreciated microRNA cluster, Mirc19, that is en-
riched in HSCs and upregulated with age. These twomicroRNAs
share a seed sequence and therefore target many of the
same genes. Several groups have demonstrated that Mirc19 is
an important regulator of immune function (Lagos et al., 2010;Immunity 42, 1021–1032, June 16, 2015 ª2015 Elsevier Inc. 1021
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Figure 1. miR-132 Is Expressed in Hematopoietic Stem Cells and Overexpression Alters Hematopoiesis
(A) miR-132 expression in mature and progenitor hematopoietic cells. Cell populations were sorted by flow cytometry directly into RNA lysis buffer and miR-132
expression was detected using TaqMan RT-qPCR (n = 3).
(B–F) WT C57BL/6 mice were lethally irradiated and reconstituted with donor bone marrow cells expressing either a control (MG) or a miR-132 overexpressing
(miR-132) retroviral vector (n = 8–12 mice per group). (B) Total numbers of mature leukocytes (CD45+) in the peripheral blood of MG and miR-132 mice at the
indicated time points post-reconstitution. (C) Total number of HSCs (LSK CD150+ CD48) in the bone marrow of MG and miR-132 mice at 8 weeks post-
reconstitution. (D) Percentage of Ki-67+ bonemarrowHSCs inMG andmiR-132mice at 8 weeks post-reconstitution. (E) Protein and RNA expression of p27 in the
bonemarrow ofMGandmiR-132mice at 8weeks post-reconstitution (n = 3). (F) Total number of LSK cells andHSCs in the bonemarrow ofMGandmiR-132mice
at 16 weeks post-reconstitution. Data represent at least three independent experiments and are represented as mean ± SEM. See also Figure S1–S3. * denotes
p < 0.05, ** denotes p < 0.01, and *** denotes p < 0.001 using a Student’s t test.Nakahama et al., 2013; Ni et al., 2014; Shaked et al., 2009). We
now show that Mirc19 plays a critical role in maintaining the bal-
ance between function and survival of aged HSCs. It does this by
buffering the expression of its target FOXO3, one of only a few
known genes associated with human longevity (Willcox et al.,
2008).
RESULTS
Enforced Expression of miR-132 Leads to Depletion of
HSCs and Extramedullary Hematopoiesis
To understand the role of themicroRNA-212/132 cluster (Mirc19)
in hematopoiesis, we first examined the expression of both mi-
croRNAs during hematopoietic differentiation. We determined
that both miR-132 and miR-212 were enriched in early hemato-
poietic progenitors (LineageSca1+cKit+; LSK cells), and in
particular, in long-term hematopoietic stem cells (HSCs:
LSK CD150+CD48; Figures 1A and S1A). We initially focused
on miR-132 because it was the more enriched of the two
microRNAs. To investigate the function of miR-132 in these
progenitors, we used a retroviral vector to ectopically express1022 Immunity 42, 1021–1032, June 16, 2015 ª2015 Elsevier Inc.miR-132 in hematopoietic stem and progenitor cells (HSPCs)
and transferred these miR-132 overexpressing cells into lethally
irradiated wild-type (WT) C57BL/6 recipient mice (Figures S1B–
S1D). We then monitored mature cell output in the peripheral
blood of these mice using flow cytometry to detect the cell-sur-
face markers that identify each cell type. Mice overexpressing
miR-132 in the bone marrow compartment (WTmiR-132), when
compared to empty vector controls (WTMG), demonstrated a
rapid accumulation of CD45+ peripheral blood leukocytes at
2 months post-reconstitution, followed by a progressive decline
in the number of these cells by 4 months (Figure 1B). A closer
inspection of the bone marrow compartment at 2 months post-
reconstitution revealed that WTmiR-132 mice displayed an expan-
sion in the total number of LSK cells and HSCs (Figure 1C and
S1D–S1F). These cells were additionally more proliferative, as
measured by the proportion of cells expressing the proliferation
marker Ki67, compared to LSK cells and HSCs from age-
matched WTMG controls (Figure 1D and S1G). WTmiR-132 HSPCs
further demonstrated a downregulation in protein and RNA
expression of several negative cell cycle regulators, including
p27 and p57, although no change in p21 transcript expression
was observed (Figure 1E and S1H). ThemRNA expression of p27
remained downregulated in WTmiR-132 HSPCs compared to
WTMG HSPCs at 4 months post-reconstitution (Figure S1I).
We next sought to characterize the cellular basis by which
WTmiR-132mice undergo depletion in peripheral blood leukocytes
at 4 months post-reconstitution. Almost two-thirds (29/44) of the
WTmiR-132 mice presented with gross pathology characteristic
of extramedullary hematopoiesis, including enlarged spleens,
and a significant elevation of splenic erythtroid cells (Ter119+)
(Figures S1J and S1K). None of the age-matched WTMG mice
presented such a phenotype and no elevation of myeloid cells
was found in the peripheral blood ofWTmiR-132 mice (Figure S1L).
Examination of the bone marrow, however, revealed that
WTmiR-132 mice had a severe depletion in the frequency and total
number of LSK cells and HSCs compared to WTMG controls
(Figure 1F, S1M, and S1N). A similar, more dramatic phenotype
was observed at 9 months post-reconstitution in WTmiR-132 mice
(Figure S1O). This phenotype of rapid proliferation followed by
depletion of HSCs in the bone marrow compartment is an
example of HSC exhaustion.
The depletion of HSCs in WTmiR-132 mice had the expected
dramatic effect on the numbers of more mature progenitor cells,
including multi-potent progenitors (MPPs; LSK CD150CD48+),
lymphoid-primed MPPs (LMPPs; LSK Flt3+), and megakaryo-
cyte and erythroid progenitors (MEPs; LineageSca1cKit+
CD34FcRg). However, no depletion in common myeloid
progenitors (CMPs; LineageSca1cKit+CD34+FcRg) or
granulocyte-myeloid progenitors (GMPs; LineageSca1cKit+
CD34+FcRg+) was observed (Figures S1P–S1T). Importantly,
the observed alteration in WTmiR-132 HSCs was intrinsic to the
expression of the miR-132 overexpression vector, because no
depletion in the proportion of HSCs was evident among the
GFP cells of WTmiR-132 and WTMG mice (Figure S1U). Further-
more, we found that the observed phenotype was specific to
the expression of authentic miR-132 because overexpression
of a miR-132mutant lacking the correct miR-132 seed sequence
resulted in no observable phenotype at 9 months post-reconsti-
tution when compared to WTMG controls (Figure S1V).
We next sought to investigate the role of miR-212 in HSC
maintenance. We found that enforced expression of miR-212
in the bone marrow compartment of mice did not result in a sig-
nificant change in the total number of bone marrow CD45+ cells
or LSK cells compared to controls (Figures S1W and S1X). How-
ever, we found that there was a significant depletion of HSCs at
4-months post-reconstitution in these mice (Figure S1Y), thus
suggesting a less severe phenotype than enforced miR-132
expression, which was consistent with the lower amounts of
enrichment of miR-212 in HSCs.
Mirc19 Has a Physiological Role of Protecting the Aging
Hematopoietic System
To determine whether miR-132 has a physiological role in regu-
lating hematopoietic stem cell function, we obtained mice that
have a genetic deletion in both of the microRNAs in the Mirc19
cluster (Mirc19/) (Ucar et al., 2012). We observed no
apparent defect in the output of mature hematopoietic cells in
the peripheral blood, spleen, and bone marrow of 12-week-
old Mirc19/ mice when compared to age-matched wild-
type (WT) controls (Figures S2A–S2D). We noticed, however,an upregulation of miR-132 expression in the bone marrow
and LSK compartment of aged (2-year-old) WT mice compared
to young (12-week-old) WT mice (Figure 2A), and posited a
more important role of miR-132 in maintaining the fidelity of
aging HSCs. Consistent with this, we found that unlike in
12-week-old mice (Figure S2D), aged (60-week-old) Mirc19/
mice had an elevation in the total number of HSCs (LSK
CD150+CD48 and LSK EPCR+) in the bone marrow compart-
ment compared to WT controls (Figure 2B). Surprisingly, this
was accompanied by a decrease in the total number of bone
marrow LSK cells, which are mostly downstream products of
HSCs (Figure 2B). Aged Mirc19/ mice further presented
with enlarged spleens (Figure S2E) and a global depletion of
all major mature cell types in the bone marrow compartment
(Figure S2F), indicative of a failure of HSCs to maintain
normal hematopoietic output and the onset of extramedullary
hematopoiesis.
To investigate the molecular basis for the role of Mirc19
in HSCs, we performed gene expression analysis by bulk popu-
lation RNA-sequencing on WT and Mirc19/ long-term HSCs
(LSK CD150+CD48), short-term HSCs (LSK CD150CD48),
and multipotent progenitors (LSK CD150CD48+). Approxi-
mately 14,000 genes were expressed in each sample (Fig-
ure S2N), and clustering based on the number differentially
expressed genes revealed close similarity between WT short-
term and long-term HSC subsets and Mirc19/ short-term
and long-term HSC subsets, with both these groups differing
significantly from the MPP populations (Figure 2C). Differentially
expressed genes between the WT and Mirc19/ HSC popula-
tions were enriched for several functional annotations relevant
to HSC biology, including regulation of cell-cycle, cell differenti-
ation, response to stress, and cell death (Figure 2D).
To investigate whether the observed phenotype in Mirc19/
mice is intrinsic to the hematopoietic system, we transferred
bone marrow cells from 12-week-old WT or Mirc19/ mice
into irradiated WT recipients. After 1 year, the phenotypes in
transplanted mice closely resembled that of aged WT and
Mirc19/ mice, respectively, consistent with a defect intrinsic
to the hematopoietic system (Figure S2G). We employed an in-
flammatory model for hematopoietic aging (Esplin et al., 2011)
to determine whether this was sufficient to recreate the
observed alteration in hematopoiesis. We delivered LPS nine
times over 1 month to 16-week-old Mirc19/ and WT mice.
We found that, consistent with the altered hematopoietic
output we observed in aged mice, Mirc19/ mice presented
with severely enlarged spleens containing an enrichment of
splenic HSCs compared to WT mice also injected with LPS
(Figures 3A and S2H). Similar to aged Mirc19/ mice, LPS-
treated Mirc19/ mice also demonstrated an accumulation
of HSCs and a decrease in the frequency of LSK cells in the
bone marrow compartment compared to LPS treated WT
controls (Figure 3B). This skewing of hematopoietic progenitor
output inMirc19/ mice might be characterized by an increase
in the total number of long-term HSCs and a reduction in total
number of short-term HSCs and MPPs in the bone marrow
compartment (Figure S2I). We can therefore mimic the aging-
related hematopoietic defect observed in Mirc19/ by
exposing younger mice to chronic inflammatory stimuli via re-
petitive LPS injections.Immunity 42, 1021–1032, June 16, 2015 ª2015 Elsevier Inc. 1023
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Figure 2. Genetic Deletion of Mirc19 in Mice Alters Hematopoietic Output with Age
(A) miR-132 expression in total bone marrow and LSK cells from 8-week-old and 2-year-old C57BL/6 WT mice. miR-132 expression was quantified by TaqMan
RT-qPCR (n = 2).
(B–D) Mice with a genetic deletion ofMirc19 (Mirc19/) along with WT mice in the C57BL/6 background were analyzed. (B) Total number of HSCs (LSK CD150+
CD48 and LSK EPCR+) and LSK cells in the bone marrow compartment of 60- to 64-week-old WT and Mirc19/ mice (n = 7–12 mice per group). (C) Global
expression profiling of WT and Mirc19/ HSCs, as well as short-term HSCs and MPPs, from 16-week-old mice using RNA-seq. The heat map represents the
number of differentially expressed genes between the different WT andMirc19/ populations. (D) Enriched gene-ontology terms for differently expressed genes
between WT and Mirc19/ progenitors. Data represent at least two independent experiments and are represented as mean ± SEM. See also Figures S4–S6.
* denotes p < 0.05, ** denotes p < 0.01, and *** denotes p < 0.001 using a Student’s t test.Loss of Mirc19 Reduces HSC Cycling and Improves
Engraftment Potential
The cycling characteristics of HSCs are closely related to their
ability to self-renew and differentiate into committed progenitors
(Pietras et al., 2011). Furthermore, increased HSC quiescence
and an increase in HSC number is characteristic of the aging
hematopoietic system (Geiger et al., 2013). We thus sought to
determine whether the accumulation of HSCs and decrease in
output of more committed progenitors in Mirc19/ mice might
be a result of altered cell cycling. We performed cell-cycling
analysis using flow cytometry by staining for the proliferation
marker Ki67 and utilizing the dsDNA dye Hoescht33342. Under
steady-state conditions, we observed no major defect in
cell cycling in 16-week-old Mirc19/ mice compared to age-
matchedWTmice (Figure S2J). However, under conditions of in-
flammatory stress such as low-grade LPS stimulation, we found
that Mirc19/ HSCs were far less proliferative, with an almost
50% increase in the number of cells in the G0 phase of the cell
cycle compared to WT HSCs (Figures 3C–3E). Importantly, we
observed a substantial decrease in the number of HSCs in G1
and only a small proportion of cells in S/M phases of the cell cy-
cle inMirc19/ mice (Figures 3C–3E). No change in p27 mRNA
expression was observed at steady state between Mirc19/
and WT HSCs. However, in mice treated with either LPS or
5-fluorouracil, which induce HSC proliferation, the expression1024 Immunity 42, 1021–1032, June 16, 2015 ª2015 Elsevier Inc.of p27 in the bone marrow compartment was upregulated in
Mirc19/ mice compared to WT mice (Figures S2K and S2L).
It therefore follows that the loss of Mirc19 leads to increased
HSC quiescence and an accumulation of HSCs, with a concom-
itant decrease in the number of more committed progenitors.
The majority of HSCs in the hematopoietic system remain in
a dormant state, and disruption of this quiescence can have
serious consequences for HSC function (Rossi et al., 2012).
To investigate whether the alteration in cell cycling of aged
Mirc19/ HSCs might be related to altered HSC function, we
performed competitive transplant assays. Aged (60 weeks)
CD45.2 Mirc19/ or WT HSCs were transplanted with equal
numbers of CD45.1 WT HSCs into lethally irradiated CD45.2
recipient mice. The peripheral blood of these mice was
analyzed at 4 months post-reconstitution for repopulation of
major mature cell types. The cells from aged Mirc19/ mice
were more effective at reconstituting most all immune cells
than those from aged WT mice, evidenced in total blood leuko-
cytes (CD45+), B cells (CD19+), myeloid cells (CD11b+), and
granulocytes (Gr-1+) in the peripheral blood (Figure 4A). An
insignificant difference in the relative proportion of T cells
(CD3ε+) was observed (Figure 4A). Competitive transplant of
young (12 weeks) Mirc19/ HSCs yielded no observable
functional difference compared to young WT HSCs except
for defective repopulation of T cells (Figure 4B); however,
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Figure 3. Genetic Deletion of Mirc19 in Mice Alters Hematopoietic Output and Cycling in Response to LPS Stimulation
(A–E) 6-month-old WT and Mirc19/ mice were treated with nine evenly-spaced low-dose (1 mg/kg of body weight) LPS or PBS injections over one month.
(A) Spleen weights of WT and Mirc19/ mice treated with PBS or LPS. (B) Proportion of HSCs and LSK cells within the bone marrow compartment of WT and
Mirc19/ mice treated with LPS or PBS. (C) Representative flow-cytometry plots for cell-cycle analysis of HSCs and LSK cells from WT and Mirc19/ mice
following LPS injection. (D) Proportion of bone marrow LSK cells and HSCs in each stage of the cell cycle (G0, G1, G2/M) fromWT andMirc19/mice following
LPS injection. (E) Proportion of bone marrow LSK cells and HSCs expressing Ki67 from WT andMirc19/ mice following LPS injection. Data represent at least
two independent experiments and are represented asmean ± SEM. See also Figures S4 and S5. * denotes p < 0.05, ** denotes p < 0.01, and *** denotes p < 0.001
using a Student’s t test.secondary transplantation of young Mirc19/ HSCs yielded a
similar phenotype to that observed with primary transplantation
of aged Mirc19/ HSCs (Figure S2M). Consistent with the
increased quiescence of aged Mirc19/ HSCs compared to
WT HSCs, Mirc19/ cells performed better at long-term repo-
pulation. Additionally, HSCs obtained from WTmiR-132 mice,
which ectopically overexpressed miR-132, were severely
defective in long-term reconstitution in competitive transplant
assays compared to control HSCs obtained from WTMG mice
(Figure 4C). It therefore appears that Mirc19 is important for
tuning the interplay between quiescence and functional output
of the aging hematopoietic system.FOXO3 Is a Target of miR-132 in Bone Marrow Cells
To understand the molecular mechanism of miR-132 action,
we characterized the expression of the best computationally
predicted targets of miR-132 from TargetScan under conditions
of miR-132 overexpression (Friedman et al., 2009). RNA was ex-
tracted from lineage-depleted bone marrow cells of WTmiR-132
and WTMG mice and was subjected to quantitative PCR
(qPCR) for target genes relevant to HSC function. The most
significantly downregulated targets under conditions of ectopic
expression of miR-132 in WTmiR-132 bone marrow, relative to
control WTMG bone marrow, were pursued for further anal-
ysis. Messenger RNA expression of several genes relevant toImmunity 42, 1021–1032, June 16, 2015 ª2015 Elsevier Inc. 1025
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A B C Figure 4. Mirc19 Regulates Long-Term
Reconstitution Potential of HSCs with Age
(A and B) WT or Mirc19/ CD45.2+ bone marrow
cells, calibrated for the total number of phenotyp-
ically defined HSCs, were injected in a 1:1 ratio with
CD45.1+ WT bone marrow cells into irradiated
C57BL/6 CD45.2+ recipients. (A) Ratio of total
CD45.2+ cells to CD45.1+ cells at 16 weeks post-
reconstitution for variousmature immune cell types
in the peripheral blood of mice injected with
aged WT and Mirc19/ CD45.2+ cells. Data was
normalized to proportion of WT CD45.2+ cells. (B) Ratio of total CD45.2+ cells to CD45.1+ cells at 16 weeks post-reconstitution for various mature immune cell
types in the peripheral blood of mice injected with young WT and Mirc19/ CD45.2+ cells.
(C) Control (MG) or miR-132 overexpressing (miR-132) bone marrow HSCs, both expressing a retroviral vector containing eGFP, were injected in a 1:1 ratio with
un-infected WT bone marrow HSCs into irradiated C57BL/6 mice. Graphs show the ratio of eGFP+ cells to eGFP cells for various immune cell types in the
peripheral blood of recipients at 16 weeks post-reconstitution. Data represent two independent experiments and are represented as mean ± SEM. * denotes
p < 0.05 using a Student’s t test.hematopoiesis was downregulated in WTmiR-132 bone marrow
samples including AchE, FOXO3, Lin28B, MMP9, and SOX4
(Figure 5A). We sought to further investigate the role of FOXO3
in mediating the effect of miR-132 on HSCs because it contains
a perfect 8-mer binding site for miR-132 (Figure 5B) and is the
most significantly downregulated of these genes. Importantly,
we also found a global upregulation of miR-132 targets in our
RNA-sequencing analysis of Mirc19/ and WT HSCs, and this
included an upregulation of FOXO3 transcript expression, as
well as some of its downstream targets (Figures S2O–S2Q).
We validated that miR-132 binds directly to the FOXO3 30-
untranslated region (30UTR) using a luciferase reporter assay in
which the FOXO3 30UTR was expressed immediately down-
stream of luciferase. We found that in the presence of miR-
132, the expression of this reporter was significantly lower than
from a vector lacking the FOXO3 30UTR (Figure 5C). This binding
was specific to miR-132 because mutating the miR-132 binding
site on the FOXO3 30UTR normalized luciferase expression
(Figure 5C).
We next quantified FOXO3 protein expression in bone marrow
cells from WTmiR-132 and WTMG mice. Consistent with FOXO3
being a target of miR-132, we found protein expression was
significantly downregulated in WTmiR-132 mice compared to
WTMG mice (Figure 5D). Expression of FOXO1 and FOXO4,
closely related family members of FOXO3, remained unchanged
in WTmiR-132 bone marrow cells (Figure S3A). Importantly, we
also found that FOXO3 mRNA and protein expression was
elevated in lineage-depleted bone marrow cells from Mirc19/
mice compared to WT controls (Figures 5E and 5F). Expression
of FOXO4 was also slightly elevated in Mirc19/ cells and
expression of FOXO1was unchanged (Figure S3B).We addition-
ally performed intracellular staining of FOXO3 and phospho-
FOXO3 (p-FOXO3) protein. As expected, we found elevated
protein expression of FOXO3 in Mirc19/ HSCs compared to
WT controls. However, we saw only a marginal elevation in
p-FOXO3 inMirc19/HSCs, indicating that themajority of extra
FOXO3 in these cells is likely in the nucleus in its active, un-phos-
phorylated state (Figures S3C and S3D). Together, the data indi-
cate that miR-132 is an important regulator of FOXO3 expression
in bone marrow cells. As was observed with miR-132 expres-
sion, FOXO3 mRNA expression was increased in bone marrow
cells from aged mice compared to those of young mice (Fig-
ure 6A), thus suggesting that miR-132 might serve to maintain1026 Immunity 42, 1021–1032, June 16, 2015 ª2015 Elsevier Inc.FOXO3 protein expression within a balanced range for normal
hematopoietic function.
miR-132 Regulates HSC Cycling and Function through
FOXO3
To determine whether FOXO3 is a keymediator of miR-132 func-
tion, we co-expressed FOXO3 with miR-132 in the bone marrow
compartment of WT mice to see whether it would rescue the
phenotype observed with miR-132 expression alone. FOXO3
cDNA lacking a miR-132 target site was cloned into the
MSCV-IRES-eGFP (MIG) vector immediately downstream of
the MSCV promoter (Figure 6B). As previously described, miR-
132 was cloned downstream of eGFP. Lethally irradiated mice
were reconstituted with bone marrow cells transduced with a
control vector (WTMIG) or a vector expressing both miR-
132 and FOXO3 (WTFOXO3+miR-132), miR-132 only (WTmiR-132),
or FOXO3 only (WTFOXO3). The expression of miR-132 and
FOXO3 was validated by qPCR and Immunoblot, respectively
(Figures S3E and S3F). We observed the mean fluorescence
intensity of eGFP in bone marrow cells expressing only FOXO3
to be lower than that of the other vectors, suggesting that over-
expression of FOXO3 above endogenous concentrations might
be toxic (Figure S3G). We additionally observed that a larger
fraction bone marrow HSCs from WTFOXO3 mice expressed
AnnexinV compared to WTMIG controls (Figure S3H). This effect
was not observed when FOXO3 was co-expressed with miR-
132, presumably because baseline expression of FOXO3 was
already downregulated due to miR-132 overexpression.
As expected, a reduction in peripheral blood leukocytes
was observed in WTmiR-132 mice compared to WTMIG mice at
4-months post-reconstitution (Figure 6C). Co-expression of
FOXO3 with miR-132, however, rescued this defect, because
no significant change in peripheral blood leukocytes was
observed in WTFOXO3+miR-132 mice compared to WTMIG controls
(Figure 6C). Examination of the bone marrow compartment of
WTFOXO3 + miR-132 mice revealed total numbers of HSCs and
LSK cells comparable to WTMIG controls, demonstrating a
rescue of HSC depletion observed with the expression of
miR-132 alone (Figures 6D and 6E). In addition, expression of
FOXO3 alone resulted in a moderate elevation in the total
number of bone marrow LSK cells compared to control mice
(Figure 6E). HSCs fromWTFOXO3+miR-132 mice also showed com-
parable proportions of Ki67 staining to HSCs from WTMIG mice,
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Figure 5. FOXO3 Is a Direct Target of miR-132 in Bone Marrow Cells
(A) mRNA expression by RT-qPCR of computationally predicted miR-132
targets in control (MG) or miR-132 overexpressing (miR-132) bone marrow
cells.
(B) Schematic of the predicted miR-132 binding site in the FOXO3 30UTR.
(C) Relative luciferase expression in 293T cells transfected with a miR-132
overexpression vector and either a vector containing luciferase only (control), a
vector containing luciferase and the FOXO3 30UTR immediately downstream
(FOXO3 30UTR), or a vector containing luciferase and a FOXO3 30UTR with a
mutated miR-132 binding site (FOXO3 30UTR mut).
(D) FOXO3 protein expression in bone marrow cells from MG and miR-132
mice obtained by Western blot.
(E) FOXO3 transcript expression in lineage-depleted bone marrow cells ob-
tained from WT or miR-212/132/ mice.
(F) FOXO3 protein expression in lineage-depleted bone marrow cells obtained
from WT or Mirc19/ mice. See also Figures S7A–S7C. Data represents at
least two independent experiments (n = 2) and is represented as mean ± SEM.
* denotes p < 0.05, ** denotes p < 0.01, and *** denotes p < 0.001 using a
Student’s t test.indicating that these cells were not prone to cycling like
WTmiR-132 cells (Figure 5F). WTFOXO3 HSCs demonstrated a sig-
nificant albeit moderate decrease in the proportion of cycling
HSCs compared to controls (Figure 6F). These experiments sug-
gest that co-expression of FOXO3 can rescue the phenotype
observed with expression of miR-132 alone. It seems likely
that miR-132 regulates hematopoiesis primarily by directly
modulating FOXO3 protein expression, although we cannot
rule out that FOXO3 overexpression is able to override the
miR-132 effect while the true targets of miR-132 in the bone
marrow are other genes.
Loss of Mirc19 Affects HSC Survival through Protective
Autophagy
FOXO3 is critical for maintaining the hematopoietic stem cell
pool by regulating HSC cell-cycling and resistance to oxidative
stress (Miyamoto et al., 2007; Tothova et al., 2007). It is also
implicated in maintaining the survival of aging HSCs by directing
protective autophagy (Warr et al., 2013). To this end, we found
that several autophagy-related genes were upregulated in
Mirc19/ HSCs compared to WT controls upon inspection of
our RNA-sequencing dataset (Figure S2R). Thus, to determine
whether miR-132 might play a role in altering survival of HSCs,
we sorted HSCs from WT and Mirc19/ mice and cultured
them in the presence or absence of survival growth factors and
cytokines including mouse stem cell factor (mSCF), mouse inter-
leukin-6 (mIL-6), mIL-3, TPO, and Flt3L. We used a luciferase-
based assay to monitor caspase activity after 12 hr in culture.
In the presence of survival factors, minimal activity was observed
in bothWT andMirc19/HSCs. However, under starvation con-
ditions, which induces protective autophagy in aged HSCs (Warr
et al., 2013),Mirc19/ HSCs demonstrated a significant reduc-
tion in induction of apoptosis compared toWT HSCs (Figure 7A).
This is consistent with the more rapid induction of a protective
autophagy program due to higher expression of FOXO3 in
Mirc19/ HSCs. Importantly, when autophagy was inhibited
by Bafilomycin A (BafA), a known inhibitor of autophagosome
fusion to lysosomes, Mirc19/ and WT HSCs underwent com-
parable, higher amounts of apoptosis (Figure 7A). As previously
reported, FOXO3 expression had no major effect on autophagy
and apoptosis of myeloid progenitors (Figure 7B).
To determine whether Mirc19/ HSCs indeed induce the
autophagy machinery more potently than WT HSCs, we utilized
a fluorescent reporter for autophagosome formation that was
detectable by flow cytometry. The efficacy of this assay in de-
tecting autophagosome formation was validated by comparing
signal intensity in WT cells to autophagy deficient cells (Fig-
ure S3I). WT and Mirc19/ HSCs were cultured under growth-
factor rich or starvation conditions as described above and
were stained for the presence of autophagosomes. Under
starvation conditions, Mirc19/ HSCs demonstrated higher
amounts of autophagosome formation comparedWTHSCs (Fig-
ure 7C). In the presence of LY2940002, a PI3-kinase inhibitor and
early inhibitor of autophagy, autophagosome formation was
decreased to comparable amounts in Mirc19/ and WT HSCs
(Figure 7C). We additionally sought to investigate whether the
potent induction of autophagy in Mirc19/ HSCs may improve
survival by altering reactive-oxygen species (ROS) accumula-
tion. We utilized a fluorescent detection system for ROS andImmunity 42, 1021–1032, June 16, 2015 ª2015 Elsevier Inc. 1027
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Figure 6. Co-expression of FOXO3 with
miR-132Rescues theHematopoietic Defects
Observed with Expression of miR-132 Alone
(A) FOXO3 mRNA expression by RT-qPCR in total
bone marrow cells from 8-week-old, 1-year-old,
and 2-year-old C57BL/6 WT mice (n = 2).
(B) Schematic of retroviral vectors constructed for
expression of FOXO3 only or for co-expression of
FOXO3 along with miR-132.
(C–F) WT C57BL/6 mice were lethally irradiated
and reconstituted with donor bone marrow cells
expressing either a control (MG), a miR-132-over-
expressing (miR-132), a FOXO3-overexpressing
(FOXO3), or a FOXO3- and miR-132-over-
expressing (FOXO3 and miR-132) retroviral vector
(n = 10–12 mice per group). (C) Total peripheral
blood CD45+ leukocytes in the respective animals
at 16 weeks post-reconstitution. (D) Total LSK cells
in the bone marrow compartment of the respective
animals at 16 weeks post-reconstitution. (E) Total
HSCs in the bone marrow compartment of the
respective animals at 16weeks post-reconstitution.
(F) Proportion of bone marrow HSCs expressing
Ki-67 in the respective animals at 16 weeks post-
reconstitution. Data represents at least two inde-
pendent experiments and is represented asmean ±
SEM. See also Figures S7E–S7H. * denotes p <
0.05, ** denotes p < 0.01, and *** denotes p < 0.001
using a Student’s t test.found thatMirc19/ HSCs had lower amounts of ROS accumu-
lation compared toWTHSCs under conditions of starvation (Fig-
ure 7D). The accumulation of ROS was elevated to comparable
amounts in WT and Mirc19/ HSCs when autophagy was in-
hibited with BafA (Figure 7D).
We employed an shRNA silencing strategy for FOXO3 to
determine whether it was the key mediator of autophagy in
Mirc19/ HSCs. WT and Mirc19/ HSPCs were transduced
with either a control vector (MB) or a FOXO3 shRNA construct
(shFOXO3) and were subsequently used to reconstitute lethally
irradiated WT mice. At 2 months post-reconstitution, we sorted
HSCs from these mice and subjected them to the aforemen-
tioned assays for autophagy induction and caspase activation
under conditions of growth factor starvation. WT HSCs express-
ing shFOXO3 demonstrated lower autophagy activity and higher
amounts of apoptosis compared to WT HSCs expressing MB
(Figures 7E and 7F). Importantly, silencing of FOXO3 in
Mirc19/ HSCs resulted in a significant reduction in autophagy
induction and an increase in caspase activity compared to
Mirc19/ HSCs expressing MB. However, this reduction did
not reduce autophagy activity completely to that ofWTHSCs ex-
pressing MB. This might be due to incomplete silencing of
FOXO3 in Mirc19/ cells or might suggest factors other than
FOXO3might be involved in mediating autophagy induction (Fig-
ures 7E and 7F).
DISCUSSION
MicroRNAs are key regulators of lineage commitment and func-
tion in immune cells (Baltimore et al., 2008; Gangaraju and Lin,1028 Immunity 42, 1021–1032, June 16, 2015 ª2015 Elsevier Inc.2009). Several microRNAs have been implicated in regulating
diverse facets of normal HSC maintenance and function, such
as cell cycling (Lechman et al., 2012; Song et al., 2013),
apoptosis (Guo et al., 2010), engraftment potential (O’Connell
et al., 2010), and resistance to inflammatory stress (Zhao et al.,
2013). Although much has been done to characterize the func-
tional differences between aged and young HSCs, little is known
about howmicroRNAs might contribute to maintaining balanced
hematopoietic output as an organism ages. Our findings suggest
that Mirc19, particularly miR-132, is critical in regulating the bal-
ance between HSC survival and proliferation and differentiation.
We have demonstrated that it does this primarily by buffering the
expression of FOXO3 in the aging hematopoietic system. Dereg-
ulation of this cluster, and in turn FOXO3, can have negative
consequences on the function of HSCs and the output of mature
hematopoietic cells, leading to extramedullary hematopoiesis.
Because the expression of miR-132 was higher in HSCs
compared to total bone marrow cells, we utilized both gain-of-
function and loss-of-function approaches to investigate its role
in HSC function and survival. Ectopic expression of miR-132 re-
sulted in hyper-proliferation and depletion of HSCs within the
bone marrow compartment. Enforced expression of miR-212
produced a similar but less dramatic phenotype. This depletion
of HSCs with miR-132 overexpression coincided with the onset
of extramedullary hematopoiesis, including enlarged spleens
and fibrotic bone marrow. We observed a drastic decrease in
protein expression of the miR-132 target FOXO3 within the
bone marrow compartment of miR-132 overexpressing mice.
Consistent with our findings, a genetic deletion of Foxo3 in he-
matopoietic cells leads to increased HSC proliferation and an
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Figure 7. Genetic Deletion of Mirc19 Results in a FOXO3-Dependent
Alteration in Autophagy and Survival of HSCs
(A and B) Cells obtained from WT and Mirc19/ mice were cultured with or
without growth cytokines (mIL3, mIL6, mSCF, TPO, Flt3L, and G-CSF) or BafA.
Caspase activation was measured using a luciferase based assay (n = 6).
(A) Caspase activation observed in HSCs fromWT andMirc19/mice with or
without growth factor starvation and BafA treatment. (B) Caspase activation
observed in myeloid progenitors from WT andMirc19/ mice with or without
growth factor starvation and BafA treatment.age-dependent depletion of the HSC pool with loss of HSC
long-term reconstitution potential (Miyamoto et al., 2007). This
phenotype is exacerbated by the concomitant deletion of the
FOXO family members Foxo1 and Foxo4 (Tothova et al., 2007).
We further found several FOXO3 target genes, particularly the
negative cell-cycle regulators p21, p57, and p27, to be downre-
gulated in miR-132 overexpressing bone marrow. Importantly,
replenishing expression of FOXO3 during miR-132 overexpres-
sion rescued the phenotype we observed.
A genetic deletion of Mirc19 led to higher basal expression of
FOXO3 in bonemarrow cells. Over time, this led to a dramatic in-
crease in the number of HSCs, a decrease in production of more
committed progenitors, and a defect in HSC cycling in response
to environmental stress, such as lipopolysaccharide treatment.
Consistent with the more quiescent state of Mirc19/ HSCs,
we found they were marginally better at long-term reconstitution
of the hematopoietic system than WT counterparts. FOXO3 is a
known regulator of apoptosis, and we further demonstrated that
ectopic expression of FOXO3 from a retroviral vector resulted in
a selection for those cells expressing the lowest amount of the
vector, presumably because higher amounts of FOXO3 expres-
sion were toxic. We have therefore shown that Mirc19 is impor-
tant in regulating expression of FOXO3, and that when this target
is either upregulated or downregulated, there is a severe alter-
ation in HSC function over time.
The expression of both miR-132 and FOXO3 transcripts is
upregulated with age in murine bone marrow cells and early
progenitors. The role of FOXO3 as a longevity-associated gene
remains unknown in the hematopoietic system. FOXO3 might
be upregulated in this context due to its vital role in survival
through autophagy and in cell cycling.MicroRNAs play an impor-
tant role in buffering perturbations in the expression of their
targets in response to environmental stress (Ebert and Sharp,
2012). Such stress might include inflammation from repetitive
exposure to environmental pathogens and hematopoietic aging.
Importantly, the abundance of microRNAs in any given cell plays
an important role in establishing a threshold for target expression
(Mukherji et al., 2011); as such, upregulation of the microRNA
may require higher target expression tomaintain important phys-
iological functions. Given that both overexpression and deletion
of miR-132 in bonemarrow cells led to inappropriate hematopoi-
esis, we believe that miR-132 plays an important role in buffering
FOXO3 protein expression within a defined range to maintain(C) Autophagy activity inWT andMirc19/HSCswith or without growth factor
starvation and LY294002 treatment. Autophagy was measured using a dye
that fluorescently labels autophagosomes (cyto-ID autophagy assay) (n = 5).
(D) ROS accumulation in WT and Mirc19/ HSCs with or without growth-
factor starvation and BafA treatment measured using a fluorescence-based
ROS detection system (CellROX assay) (n = 5).
(E and F) WT C57BL/6 mice were lethally irradiated and reconstituted with WT
or Mirc19/ donor bone marrow cells expressing either a control or FOXO3
shRNA silencing vector. At 8 weeks post-reconstitution HSCs were sorted
from bone marrow and assays were performed. (E) Autophagy activity
measured in HSCs from the respective mice in response to growth factor
starvation (n = 6). (F) Caspase activation measured in HSCs from the
respectivemice in response to growth factor starvation (n = 6). Data represents
two independent experiments and is represented as mean ± SEM. See also
Figure S7I. * denotes p < 0.05, ** denotes p < 0.01, and *** denotes p < 0.001
using a Student’s t test.
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normal HSC function as an organism ages. The concomitant
increase in the expression of miR-132 alongside FOXO3 in the
aging hematopoietic system might be critical for maintaining
an important balance between known FOXO3-regulated pro-
cesses, including cell-cycling and differentiation, and apoptosis
of HSCs.
The aging hematopoietic system is characterized by an alter-
ation of the balance between self-renewal and differentiation,
which leads to the accumulation of less-functional HSCs,
myeloid-biased differentiation, and a requirement for basal auto-
phagy for survival (Geiger et al., 2013; Warr et al., 2013). Of note,
the loss of critical autophagy factors in the hematopoietic system
leads to hyper-proliferation and poor survival of HSCs (Morten-
sen et al., 2011). Recently, it has also been demonstrated that
FOXO3 plays a critical role in inducing protective autophagy of
aging HSCs (Warr et al., 2013), which is critical for their survival
in response to oxidative stress (Eijkelenboom and Burgering,
2013). The proposed mechanism of FOXO3 regulation of auto-
phagy is through the transcription of glutamine synthase (van
der Vos et al., 2012). Consistent with this role of FOXO3 in
HSC survival, we found that Mirc19/ HSCs, when compared
to WT HSCs, demonstrated increased resistance to growth-
factor starvation as evidenced by the decrease in presence of
reactive oxygen species, lower amounts of apoptosis induction,
and an increase in accumulation of autophagosomes. We
observed an abrogation of this effect when we silenced
FOXO3 inMirc19/ HSCs, thus demonstrating that this pheno-
type is mostly due to the upregulation of FOXO3 in these cells.
Importantly, this improved survival ofMirc19/ cells in response
to environmental stress might contribute to the age-dependent
accumulation of HSCs inMirc19/mice compared to WTmice.
Our observations demonstrate that theMirc19/ cluster is an
important regulator of HSC homeostasis by altering cell cycling,
function, and survival. This is an example of a microRNA playing
a physiological role in maintaining the balance of HSC functions
during aging. The capacity of this microRNA to buffer expression
of FOXO3 is critical given the multiple roles FOXO3 plays in regu-
lating HSC biology. Our findings open the possibility of utilizing
miR-132 mimics or antagonists to alter defects in HSC function
that might lead to hematopoietic diseases late in life.EXPERIMENTAL PROCEDURES
DNA Constructs
For in vivo miR-132 overexpression and FOXO3 shRNA experiments, the
mature miR-132 or FOXO3 shRNA sequence was placed in the microRNA-
155 loop-and-arms format (O’Connell et al., 2010) and cloned into the MSCV-
eGFP (MG) and MSCV-TagBFP (MG) vectors, respectively. For FOXO3 rescue
experiments, FOXO3 cDNA was cloned into the MSCV-IRES-eGFP (MIG)
vector. See Supplemental Experimental Procedures for more details about
these vectors. FOXO3 shRNA target sequences are given in Table S1.
For luciferase assays, the microRNA-132 expression cassette was sub-
cloned into the pCDNA3 vector. The 30untranslated regions of relevant gene
targets containing themiR-132 binding region were cloned immediately down-
stream of luciferase in the pMiReport vector as previously described (Chaud-
huri et al., 2012).
Cell Culture
Cells were cultured in a sterile incubator that was maintained at 37C and 5%
CO2. 293T cells were cultured in DMEM supplemented with 10% fetal bovine
serum, 100 U/mL penicillin and 100 U/mL streptomycin. Primary cells were1030 Immunity 42, 1021–1032, June 16, 2015 ª2015 Elsevier Inc.cultured in complete RPMI supplemented with 10% FBS, 100 U/mL penicillin,
100 U/mL streptomycin, 50 mM b-mercaptoethanol, and appropriate growth
cytokines as needed for the experiment.
Cell Sorting for RNA Extraction
For miR-132 expression profiling, bone marrow cells from C57BL/6 mice were
depleted of RBCs and sorted for the respective cell populations at the Caltech
Flow Cytometry Core Facility. Detailed procedures are provided in the Supple-
mental Experimental Procedures. RNA was harvested using the miRNAeasy
RNA prep kit (QIAGEN). For bone marrow samples from MG and miR-132
mice, bonemarrowwas harvested from the respectivemice, lysed of red blood
cells, and spun down. RNA was harvested as described above.
Expression Profiling and qPCR
Weperformed real time qPCR (RT-qPCR) with a 7300 Real-Time PCRmachine
(Applied Biosystems) as previously described (Chaudhuri et al., 2012). Taq-
Man qPCR was performed for miR-132, miR-212, and snoRNA-202 (control)
detection as per manufacturer’s instructions using TaqMan MicroRNA Assays
(Life Technologies). SYBR Green-based RT-qPCR was performed for mRNA
of mouse FOXO3, FOXO1, p27, p21, p57, and relevant miR-132 targets
following cDNA synthesis using qScript cDNA SuperMix (Quanta) and detec-
tion with PerfeCTa qPCR Fastmix with ROX (Quanta) as per manufacturer’s
instructions. Gene-specific primers used for qPCR are listed in Table S2.
RNA-seq library construction and analysis are described in the Supplemental
Information.
Target Prediction and Luciferase Reporter Assays
Relevant targets for miR-132 were investigated using predictions from Tar-
getScan Mouse 6.2 software (Friedman et al., 2009) and following sorting by
probability of conserved targeting (PCT). Luciferase assays for miR-132 targets
were performed as previously described (Chaudhuri et al., 2012). Briefly, 4 3
105 cells were plated in 12-well plates for 24 hr and subsequently transfected
with either pCDNA or pCDNA-miR-132, a pMiReport vector, and a b-gal
expression vector. 48 hr later, cells were lysed using Reporter Lysis Buffer
(Promega) and luciferase and b-gal expression was analyzed, respectively, us-
ing a Dual Luciferase Kit (Promega) and a chemiluminescent b-gal reporter kit
(Roche).
Immunoblotting
Bone marrow samples were prepared as described for RNA preparation. Cell
extracts were collected using RIPA lysis buffer (Sigma) and were subjected to
gel-electrophoresis and transfer onto a PVDF membrane. Antibody staining
was performed using antibodies for FOXO3, p27, and actin. Detailed proce-
dures are given in the Supplemental Information.
Animals
The California Institute of Technology Institutional Animal Care and Use
Committee approved all experiments. C57BL/6 WT and miR-212/132/
mice were bred and housed in the Caltech Office of Laboratory Animal
Resources (OLAR) facility. Bone marrow reconstitution experiments were
performed as previously described (Chaudhuri et al., 2012) with the afore-
mentioned vectors and are explained in more detail in the Supplemental
Experimental Procedures. Recipient mice were monitored for health and pe-
ripheral blood was analyzed for mature blood cell types each month up till
the experimental end-point at either 16 or 36 weeks post-reconstitution. At
each end-point, immune organs were harvested for further analysis as
described. The number of mice for each experimental cohort is described
in the figure legends. Each experiment was repeated at least twice and, in
many cases, three or four times.
Competitive Transplant Experiments
Bonemarrow cells from age and gender-matchedWTCD45.2+ C57BL/6mice,
Mirc19/ CD45.2+ C57BL/6 mice, and WT CD45.1+ C57BL/6 mice were har-
vested and depleted of RBCs as described above. A 1:1 ratio of WT CD45.1+
HSCs with either WT or Mirc19/ CD45.2+ HSCs was subsequently injected
into lethally irradiated (1,000 rads) WT CD45.2+ CD57BL/6 mice. Mice were
monitored for up to 20 weeks post-reconstitution and relevant tissues were
harvested for further analysis by flow cytometry.
Flow Cytometry
Relevant tissues were harvested and cells were homogenized and subse-
quently depleted of red blood cells as described above. Flurophore-conju-
gated antibodies were used for the indicated markers, and detected using a
MACSQuant10 Flow Cytometry machine (Miltenyi). Detailed procedures are
given in the Supplemental Information.
Autophagy and Reactive-Oxygen Species Assays
HSCs were sorted as described above from either WT or Mirc19/
C57BL/6 mice, or from reconstituted mice with donor WT or Mirc19/
bone marrow infected with either MB or shFOXO3 retroviral constructs.
Cells were then cultured with the appropriate growth factors and cyto-
kines, or authophagy inhibitors, and processed for caspase activity
(Promega), the presence of ROS (Life Technologies), or autophagy activity
(Enzo Life Sciences). Detailed procedures are given in the Supplemental
Information.
Statistical Tests
All statistical analysis was done in Graphpad Prism software using an unpaired
Student’s t test. Data were reported as mean ± SEM. Significance measure-
ments were marked as follows: * p < 0.05, ** p < 0.01, ** p < 0.001, or ns for
not significant.
ACCESSION NUMBER
The RNA-seq data used in this study can be accessed from the Gene Expres-
sion Omnibus under the accession project ID GSE66352.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2015.05.017.
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